Ledger.Open graph →

SEC Form D · Amendment · filed January 9, 2019

PHOENIX BIOTECHNOLOGY INC

Offering

—

Sold

$1.0M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

SAN ANTONIO, TX

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

John W. Creamer · San Antonio, TXDirector Jeffrey S. Thompson · San Antonio, TXDirector Andrew J. Butler · San Antonio, TXDirector Lou T. Kost · San Antonio, TXExec · Director Crandell Addington · San Antonio, TXExec · Director Macdonald T. Haskell · San Antonio, TXDirector Robert A. Newman · San Antonio, TXExec · Director David W. Davis · Louisville, KYDirector Stephen S. Sypherd · Philadelphia, PADirector Gary T. Salhany · Cuyahoga Falls, OHExec · Director Tadataka M. Yamada · Seattle, WAExec · Director W. M. Bryant · Louisville, KYDirector Greg F. Gruning · Cuyahoga Falls, OHExec · Director Mark Hauser · New York, NYDirector Richard G. Kent · London, United KingdomDirector Frank Sena · SEATTLE, WADirector Robb Monkman · SEATTLE, WADirector Brian K. Sullivan · Canton, GAExec · Director Chris Allen · Alpharetta, GAExec · Director IgniteXL Ventures GP, LLC · Palo Alto, CADirector Michael Hacke · Pittsburgh, PAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗